Stockpiles of pre-pandemic influenza countermeasures, domestic vaccine manufacturing capacity, and procure vaccine interventions, including vaccines and therapeutics to mitigate the public health…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75A50122D00003
- Awardee
-
Sanofi Vaccines US Inc. UEI NCXBGGQ8YTU9
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Task orders
- 14 $74,976,007 obligated
Award facts
- Opportunity
-
- Acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza and Emerging Diseases Preparedness and Response Solicitation · 75A50121R00013 · Posted Jun 29, 2021
- Combined order value
-
- $74,976,007 Current, with exercised options
- $167,400,743 Potential, with all options
- Last date to order 94% complete
- IDV ceiling 1% used
- $5,869,454,070.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Office of the Assistant Secretary for Preparedness and Response awarded an indefinite-delivery contract to Sanofi Vaccines US Inc. on February 22, 2022, with a ceiling of $5.869 billion to procure stockpiles of pre-pandemic influenza countermeasures, support domestic vaccine manufacturing capacity, and acquire vaccines and therapeutics to mitigate the public health impact of emerging disease threats. This is a single-award contract with no set-aside designation.
Place of performance is Swiftwater, Pennsylvania. The originating solicitation, posted June 29, 2021 and closed September 13, 2021, sought an indefinite-delivery/indefinite-quantity vehicle to acquire medical countermeasures including master seed lots, investigational vaccine lots, bulk antigen and adjuvant, fill-finish, stability studies, shipping, testing, and reporting over five years. The minimum guarantee was $50,000. The contract runs through February 21, 2027 (base 36 months plus two 12-month options). NAICS code is 325414 (biological product manufacturing); PSC code is 6505 (Drugs and Biologicals).
Delivery orders issued under this IDIQ focus on pandemic preparedness and emerging influenza response. Recent orders include a $19.449 million firm fixed-price delivery order issued September 30, 2026, for manufacture and stability studies of thimerosal-free pandemic influenza vaccine multidose vials (completion September 29, 2028); a $24.873 million order from September 5, 2025, for a clinical trial assessing Matrix-M adjuvant in combination with A/Astrakhan H5N8 influenza vaccine (completion September 4, 2028); and a $93.349 million order from May 9, 2024, for acquisition and delivery of vaccines and adjuvants for pandemic influenza and emerging diseases preparedness (completion May 9, 2026). Earlier orders through 2022 address H5N1 and H7N9 seed lots, storage and stability of vaccine bulks, and medical countermeasures for HHS-designated pandemic preparedness requirements. All orders cite Swiftwater, Pennsylvania as place of performance and carry firm fixed-price pricing with no set-asides.
Description
Stockpiles of pre-pandemic influenza countermeasures, domestic vaccine manufacturing capacity, and procure vaccine interventions, including vaccines and therapeutics to mitigate the public health impact of emerging disease threats.
Task orders
Show all 14
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75A50122D00003?
75A50122D00003 was awarded to Sanofi Vaccines US Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 22, 2022.
How much is contract 75A50122D00003 worth?
Orders under 75A50122D00003 have obligated $74,976,007. Their combined potential value, with all options, is $167,400,743. 75A50122D00003's own ceiling is $5,869,454,070.
How many orders have been placed under contract 75A50122D00003?
14 orders have been placed under 75A50122D00003, the latest on September 30, 2026.
Who can order from contract 75A50122D00003?
75A50122D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75A50122D00003 competed?
The extent of competition for 75A50122D00003 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV